| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| R&D Expense | $6.1M | -20.9% |
| SG&A Expense | $9.1M | +38.6% |
| Operating Income | -$15.2M | -8.6% |
| Interest Expense | $1.5M | +288.4% |
| Pre-tax Income | -$16.6M | -8.5% |
| Income Tax | $0 | — |
| Net Income | -$16.6M | -8.5% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.1M | -61.2% |
| Current Assets | $3.1M | -61.2% |
| Total Assets | $3.7M | -55.7% |
| Current Liabilities | $5.2M | +14.2% |
| Total Liabilities | $5.8M | +28.7% |
| Stockholders' Equity | -$2.2M | -157.6% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.8M | -23.9% |
| Capital Expenditures | $66K | -17.9% |
| Investing Cash Flow | -$66K | +17.9% |
| Financing Cash Flow | $8.0M | +36.1% |
| Free Cash Flow | -$12.9M | -23.6% |